The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome

被引：99

作者：

Frere, C. ^{[1
]}

Cuisset, T. ^{[1
,2
]}

Gaborit, B. ^{[1
]}

Alessi, M. -C. ^{[1
]}

Hulot, J. -S. ^{[3
]}

机构：

[1] CHU Timone, INSERM, Fac Med, Hematol Lab,U626, F-13385 Marseille 05, France

[2] CHU Timone, Dept Cardiol, F-13385 Marseille, France

[3] Hop La Pitie Salpetriere, Unite Pharmacogenet, Serv Pharmacol, Paris, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 08期

关键词：

OF-FUNCTION POLYMORPHISM; INDIVIDUAL RESPONSIVENESS; SEQUENCE VARIATIONS; VARIABILITY; INTERVENTION; REACTIVITY; METABOLISM; COMMON;

D O I：

10.1111/j.1538-7836.2009.03500.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1409 / 1411

页数：3

共 13 条

[1] Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives [J].

Angiolillo, Dominick J. ;

Fernandez-Ortiz, Antonio ;

Bernardo, Esther ;

Alfonso, Fernando ;

Macaya, Carlos ;

Bass, Theodore A. ;

Costa, Marco A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (14) :1505-1516

[2] Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel [J].

Angiolillo, Dominick J. ;

Fernandez-Ortiz, Antonio ;

Bernardo, Esther ;

Ramirez, Celia ;

Cavallari, Ugo ;

Trabetti, Elisabetta ;

Sabate, Manel ;

Hernandez, Rosana ;

Moreno, Raul ;

Escaned, Javier ;

Alfonso, Fernando ;

Banuelos, Camino ;

Costa, Marco A. ;

Bass, Theodore A. ;

Pignatti, Pier Franco ;

Macaya, Carlos .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) :1895-1900

[3] Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study [J].

Collet, Jean-Philippe ;

Hulot, Jean-Sebastien ;

Pena, Anna ;

Villard, Eric ;

Esteve, Jean-Baptiste ;

Silvain, Johanne ;

Payot, Laurent ;

Brugier, Delphine ;

Cayla, Guillaume ;

Beygui, Farzin ;

Bensimon, Gilbert ;

Funck-Brentano, Christian ;

Montalescot, Gilles .

LANCET, 2009, 373 (9660) :309-317

[4] Effect of cytochrome P450 polymorphisms on platelet reactivity after treatment with Clopidogrel in acute coronary syndrome [J].

Frere, Corinne ;

Cuisset, Thomas ;

Morange, Pierre-Emmanuel ;

Qpilici, Jacques ;

Camoin-Jaumd, Laurence ;

Saut, Noemie ;

Faille, Dorothee ;

Lambert, Marc ;

Juhan-Vague, Irene ;

Bonnet, Jean-Louis ;

Alessi, Marie-Christine .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (08) :1088-1093

[5] Cytochrorne P4502C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects [J].

Hulot, Jean-Sebastien ;

Bura, Alessandra ;

Villard, Eric ;

Azizi, Michel ;

Remones, Veronique ;

Goyenvalle, Catherine ;

Aiach, Martine ;

Lechat, Philippe ;

Gaussem, Pascale .

BLOOD, 2006, 108 (07) :2244-2247

[6] Cytochrome P-450 Polymorphisms and Response to Clopidogrel. [J].

Mega, Jessica L. ;

Close, Sandra L. ;

Wiviott, Stephen D. ;

Shen, Lei ;

Hockett, Richard D. ;

Brandt, John T. ;

Walker, Joseph R. ;

Antman, Elliott M. ;

Macias, William ;

Braunwald, Eugene ;

Sabatine, Marc S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (04) :354-362

[7] IMPORTANCE OF HEPATIC-METABOLISM IN THE ANTIAGGREGATING ACTIVITY OF THE THIENOPYRIDINE CLOPIDOGREL [J].

SAVI, P ;

HERBERT, JM ;

PFLIEGER, AM ;

DOL, F ;

DELEBASSEE, D ;

COMBALBERT, J ;

DEFREYN, G ;

MAFFRAND, JP .

BIOCHEMICAL PHARMACOLOGY, 1992, 44 (03) :527-532

[8]

SAVI P, 1994, J PHARMACOL EXP THER, V269, P772

[9] Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention [J].

Sibbing, Dirk ;

Stegherr, Julia ;

Latz, Wolfgang ;

Koch, Werner ;

Mehilli, Julinda ;

Doerrler, Katharina ;

Morath, Tanja ;

Schoemig, Albert ;

Kastrati, Adnan ;

von Beckerath, Nicolas .

EUROPEAN HEART JOURNAL, 2009, 30 (08) :916-922

[10] A common novel CTP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants [J].

Sim, SC ;

Risinger, C ;

Dahl, ML ;

Aklillu, E ;

Christensen, M ;

Bertilsson, L ;

Ingelman-Sundberg, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (01) :103-113

← 1 2 →